Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of M184V on the Virological Efficacy to Lamivudine/Dolutegravir

NCT04568239 is registered in ClinicalTrials.gov with Association de Recherche en Virologie et Dermatologie as lead sponsor.

NCT NCT04568239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04568239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of M184V on the Virological Efficacy to Lamivudine/Dolutegravir
Lead sponsor
Association de Recherche en Virologie et Dermatologie
Phase
Observational
Overall status
Completed
Start date
September 1, 2020
Completion date
August 1, 2022
Enrollment
712 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection